118 medical and health institutions took the lead in implementing the two-vote system for inspection and testing reagents
In recent years, the state has taken active measures to deepen medical reform and further improve the centralized procurement and supply guarantee mechanism for inspection and testing reagents in China to ensure the quality of inspections and reduce the burden of medical treatment for people. The provinces actively responded to the call of the state and introduced effective measures. The Heilongjiang Health Planning Commission issued a notice stipulating that from April 30, the first batch of inspection results in Heilongjiang Province will recognize 118 pilot medical and health institutions to take the lead in implementing the two-vote system for inspection and testing reagents, and encourage other medical and health institutions to refer to implementation. In this way, we will further promote the mutual recognition of inspection results in the province.
On March 21, according to the Heilongjiang Provincial Health Planning Commission, in order to further promote the mutual recognition of the inspection results of the province, and draw on the advanced experience of the provinces, combined with the actual situation of Heilongjiang Province, the Provincial Health Planning Commission and the Provincial Medical Reform Office, the Provincial Administration of Traditional Chinese Medicine Issued the "Notice on Deeply Advancing the Mutual Recognition of Inspection Results of Medical Institutions at the Same Level and Implementing the Two-Ticket System for Inspection and Testing Reagents", stipulating that from April 30, the first batch of inspection results in Heilongjiang Province will recognize 118 pilot medical and health institutions to be the first to implement The two-vote system for the inspection and testing reagents is purchased, and other medical and health institutions are encouraged to refer to the implementation.
According to the relevant person in charge of the Heilongjiang Provincial Health Planning Commission, the implementation of the two-vote system for inspection and testing reagents is an important part of deepening medical reform. The implementation of the two-vote system will further improve the centralized procurement and supply guarantee mechanism for inspection and testing reagents, standardize the purchase and sale behavior of medical institutions, reduce false high prices, ensure the quality of inspections, and effectively reduce the burden of medical treatment for the people.
The general requirement for the implementation of the two-vote system for inspection and testing reagents is to further standardize the procurement and distribution management of inspection and testing reagents, purify the circulation environment, improve the distribution efficiency, ensure the uniformity of the cold-chain standards for inspection and testing reagents, and ensure the orderly and effective operation of unified procurement and distribution. We will vigorously promote the smooth implementation of the Mutual Recognition Project for Inspection Results in Heilongjiang Province.
According to the relevant national documents, the two-vote system refers to the inspection and testing reagents from the production enterprise to the operating enterprise to open an invoice, the operating enterprise to the medical and health institutions to open an invoice. It is specifically defined as: a wholly-owned or holding commercial company established by a group-type enterprise that is inspected by a testing reagent manufacturer or a combination of science, industry and trade, and a domestic distributor of overseas inspection and testing reagents. 1) can be regarded as the same as the production enterprise; the inspection and testing reagents listed on the license holder entrusts the inspection and testing reagent production enterprise or the operating enterprise to sell the inspection and testing reagents, which can be regarded as the same as the production enterprise; the inspection and testing reagents operate within the group-type enterprise to be wholly-owned or The holding subsidiary's transfer inspection and testing reagents may not be regarded as one vote, but at most one invoice may be allowed; in the case of natural disasters, major epidemics, major emergencies, emergency (rush) rescue, etc., or clinically necessary but less The test and test reagents can be used without a two-vote system.
Diagnostic reagents can be divided into two categories: in vivo diagnostic reagents and in vitro diagnostic reagents. It is mostly a reagent for detection by the reaction between antigen and antibody.
A: Classification of in vitro diagnostic reagents:
1. In vitro biodiagnostic reagents managed as drugs include:
1. Blood type and tissue type reagents;
2. Microbial antigen, antibody and nucleic acid detection reagents;
3. Tumor marker reagents;
4. Immunohistochemistry and human tissue cell reagents;
5. Human genetic testing reagents;
6. Biochips;
7. Allergy diagnostic reagents.
2. In vitro reagents managed as medical devices include:
1. Clinical basic test reagents;
2. Clinical chemistry reagents;
3. Blood gas and electrolyte determination reagents;
4. Vitamin determination reagents;
5. Cell histochemical stains;
6. Autoimmune diagnostic reagents;
7. Microbiological test reagents.
B: According to medical test items, clinical diagnostic reagents can be roughly divided into clinical chemical test reagents, immunology and
Serological testing reagents, hematological and cytogenetic testing reagents, microbiological testing reagents, body fluid excretion
Detection reagents, genetic diagnosis reagents, etc. Among them, the market share of clinical chemistry
The largest, close to 34%; followed by the immunology market, accounting for about 29%. Novel immunodiagnostic reagents and genetic diagnostic tests
The reagent was developed in the late 1980s, and it is the most common diagnostic reagent for all current diagnostic reagents, regardless of technology or market.
The fastest growing product.
Urine Rapid Test Kit,Rapid Test Kit 6-Panel,Toxoplasma rapid test kits,Fecal Occult Blood Test
Jilin Sinoscience Technology Co. LTD , https://www.jilinsinoscience.com